HOT NEWS
Roche
RocheHeadquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totalled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at www.roche.com.

Roche RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Innovative cervical screening app launches in UK and Ireland 1657
2 Roche obtains EU approval for PERJETA, a new personalised treatment for aggressive type of breast cancer 2176
3 Roche to invest 240 million Swiss francs in diagnostics production in Germany 4374
4 Roche underscores leadership in oncology with new data in HER2 positive breast cancer and skin cancer 3167
5 The Phase III AVAglio study met its co-primary endpoint 2378
6 Roche's Zelboraf receives EU approval for the treatment of people with deadly form of skin cancer 4854
7 Roche in 2011: Strong results and positive outlook 4332
8 Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer 5612
9 Roche's personalized medicine Zelboraf receives positive opinion 5629
10 Roche reports positive study of Herceptin given by subcutaneous injection 5354
11 Roche wins first major public tender in Europe to screen women for cervical cancer 5747
12 Roche highlights data at 2011 European Multidisciplinary Cancer Congress 5794
13 Roche's Tarceva receives European approval for first-line use in a genetically distinct type of lung cancer 5414
14 Roche's RoACTEMRA approved in Europe for children living with a rare and severe form of arthritis 6078
15 "Roche Continents" at the Salzburg Festival celebrates its five-year anniversary 5391
16 Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing 4754
17 Roche’s Avastin receives broader EU label for women with metastatic breast cancer 5099
18 Pivotal study showed vismodegib helped shrink tumours or heal lesions 5272
19 New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer 5272
20 Roche Group's first-quarter 2011 sales on track for full-year targets 4616
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »
Page 1 of 4